Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Unleashing the therapeutic potential of human kallikrein-related serine proteases.

Prassas I, Eissa A, Poda G, Diamandis EP.

Nat Rev Drug Discov. 2015 Mar;14(3):183-202. doi: 10.1038/nrd4534. Epub 2015 Feb 20.

PMID:
25698643
[PubMed - in process]
2.

Delineating monoclonal antibody specificity by mass spectrometry.

Korbakis D, Prassas I, Brinc D, Batruch I, Krastins B, Lopez MF, Diamandis EP.

J Proteomics. 2015 Jan 30;114:115-24. doi: 10.1016/j.jprot.2014.11.004. Epub 2014 Nov 15.

PMID:
25462431
[PubMed - in process]
3.

Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer.

Chan A, Prassas I, Dimitromanolakis A, Brand RE, Serra S, Diamandis EP, Blasutig IM.

Clin Cancer Res. 2014 Nov 15;20(22):5787-95. doi: 10.1158/1078-0432.CCR-14-0289. Epub 2014 Sep 19.

PMID:
25239611
[PubMed - in process]
4.

Mining for single nucleotide variants (SNVs) at the kallikrein locus with predicted functional consequences.

Sukumar N, Scott E, Dimitromanolakis A, Misiak A, Prassas I, Diamandis EP, Konvalinka A.

Biol Chem. 2014 Sep;395(9):1037-50. doi: 10.1515/hsz-2014-0136.

PMID:
25153386
[PubMed - in process]
5.

Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry.

Cretu D, Prassas I, Saraon P, Batruch I, Gandhi R, Diamandis EP, Chandran V.

Clin Proteomics. 2014 Jul 1;11(1):27. doi: 10.1186/1559-0275-11-27. eCollection 2014.

PMID:
25097465
[PubMed]
Free PMC Article
6.

A multiparametric serum marker panel as a complementary test to mammography for the diagnosis of node-negative early-stage breast cancer and DCIS in young women.

Lacombe J, Mangé A, Bougnoux AC, Prassas I, Solassol J.

Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1834-42. doi: 10.1158/1055-9965.EPI-14-0267. Epub 2014 Jun 23.

PMID:
24957886
[PubMed - in process]
7.

Putative kallikrein substrates and their (patho)biological functions.

Yu Y, Prassas I, Diamandis EP.

Biol Chem. 2014 Sep;395(9):931-43. doi: 10.1515/hsz-2014-0129.

PMID:
24854536
[PubMed - in process]
8.

In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers.

Karagiannis GS, Pavlou MP, Saraon P, Musrap N, Xie A, Batruch I, Prassas I, Dimitromanolakis A, Petraki C, Diamandis EP.

J Proteomics. 2014 May 30;103:121-36. doi: 10.1016/j.jprot.2014.03.018. Epub 2014 Mar 27.

PMID:
24681409
[PubMed - indexed for MEDLINE]
9.

Translational researchers beware! Unreliable commercial immunoassays (ELISAs) can jeopardize your research.

Prassas I, Diamandis EP.

Clin Chem Lab Med. 2014 Jun;52(6):765-6. doi: 10.1515/cclm-2013-1078. No abstract available.

PMID:
24497227
[PubMed - indexed for MEDLINE]
10.

False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125.

Prassas I, Brinc D, Farkona S, Leung F, Dimitromanolakis A, Chrystoja CC, Brand R, Kulasingam V, Blasutig IM, Diamandis EP.

Clin Chem. 2014 Feb;60(2):381-8. doi: 10.1373/clinchem.2013.215236. Epub 2013 Oct 4.

PMID:
24097894
[PubMed - indexed for MEDLINE]
Free Article
11.

Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues.

Kosanam H, Prassas I, Chrystoja CC, Soleas I, Chan A, Dimitromanolakis A, Blasutig IM, Rückert F, Gruetzmann R, Pilarsky C, Maekawa M, Brand R, Diamandis EP.

Mol Cell Proteomics. 2013 Oct;12(10):2820-32. doi: 10.1074/mcp.M112.023507. Epub 2013 Jun 24.

PMID:
23798558
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Bioinformatic identification of proteins with tissue-specific expression for biomarker discovery.

Prassas I, Chrystoja CC, Makawita S, Diamandis EP.

BMC Med. 2012 Apr 19;10:39. doi: 10.1186/1741-7015-10-39.

PMID:
22515324
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis.

Karagiannis GS, Petraki C, Prassas I, Saraon P, Musrap N, Dimitromanolakis A, Diamandis EP.

Oncotarget. 2012 Mar;3(3):267-85.

PMID:
22408128
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Digitoxin-induced cytotoxicity in cancer cells is mediated through distinct kinase and interferon signaling networks.

Prassas I, Karagiannis GS, Batruch I, Dimitromanolakis A, Datti A, Diamandis EP.

Mol Cancer Ther. 2011 Nov;10(11):2083-93. doi: 10.1158/1535-7163.MCT-11-0421. Epub 2011 Aug 22.

PMID:
21859838
[PubMed - indexed for MEDLINE]
Free Article
15.

The canine kallikrein-related peptidase 14: structural characterization, alternative splicing and differential expression in mammary cancer.

Angelopoulou K, Prassas I, Yousef GM.

Gene. 2009 Oct 15;446(2):68-74. doi: 10.1016/j.gene.2009.07.007. Epub 2009 Jul 17.

PMID:
19619623
[PubMed - indexed for MEDLINE]
16.

Novel therapeutic applications of cardiac glycosides.

Prassas I, Diamandis EP.

Nat Rev Drug Discov. 2008 Nov;7(11):926-35. doi: 10.1038/nrd2682. Epub 2008 Oct 24. Review.

PMID:
18948999
[PubMed - indexed for MEDLINE]
17.

High-throughput screening identifies cardiac glycosides as potent inhibitors of human tissue kallikrein expression: implications for cancer therapies.

Prassas I, Paliouras M, Datti A, Diamandis EP.

Clin Cancer Res. 2008 Sep 15;14(18):5778-84. doi: 10.1158/1078-0432.CCR-08-0706.

PMID:
18794087
[PubMed - indexed for MEDLINE]
Free Article
18.

Evaluation of a transfer medium containing high concentration of hyaluronan in human in vitro fertilization.

Loutradi KE, Prassas I, Bili E, Sanopoulou T, Bontis I, Tarlatzis BC.

Fertil Steril. 2007 Jan;87(1):48-52. Epub 2006 Oct 30.

PMID:
17074336
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk